BioSpace News Archive

Evolution Optiks Limited announced today that Prof. Dr. Thomas Neuhann had joined the ranks of experts serving on the Advisory Board of the company.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of seven abstracts in Parkinson’s disease (PD) at the 9th Congress of the European Academy of Neurology (EAN), which was held in Budapest, July 1-3 , and the 6th World Parkinson Congress (WPC), being held in Barcelona, July 4-7.

The Kleine-Levin Syndrome Foundation today announced updated diagnostic criteria for Kleine-Levin Syndrome (KLS) published in the International Classification of Sleep Disorders Third Edition.

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, is set to unveil its “PURE Genius” food safety program at the 2023 International Association for Food Protection (IAFP) show in Toronto, Ontario, Canada on July 16th -19th, 2023.

Liberate Medical, an emerging leader in the development of novel non-invasive neurostimulation devices focused on transforming respiratory care, announced today the successful closure of its $6.2M Series B financing round.

Designation confers advantages including marketing exclusivity and tax credits Padeliporfin VTP Phase 1 trial in Pancreatic cancer to start by end Q4 2023 TEL AVIV, Israel, July 05, 2023 (GLOBE NEWSWIRE) -- ImPact Biotech , the IM mune P hoto A ctivated C ancer T reatment (IMPACT) specialist announces the U.S. Food and Drug Administration granted Orphan Drug Designation (ODD) to Padeliporfin Vascular Targeted Photodynamic therapy (VTP) for the treatment of patients with local